CW23. Evaluating Competency in Psychosomatic MedicineAPA
Council on Psychosomatic Medicine; Chair: Mary Jane Massie, M.D.
CW24. Culture Matters: A Multicultural Perspective on the Immigrant
ExperienceAPA/AstraZeneca Minority Fellows; Chair: Alejandra
CW25. Sweet Child of Mine: Pregnancy and Parental Leave During
ResidencyAPA/GlaxoSmithKline Fellows; Chair: Vishal Madaan,
CW26. The APA Web Site: Potential Future Directions and Opportunity for
DialogueAPA Ad Hoc Work Group on Information Systems; Chair: Robert
C. Hsiung, M.D.
CW27. Update on Psychiatry and LawAPA Council on Psychiatry and
Law; Chair: Paul S. Appelbaum, M.D.
CW28. Learning Disorders Update for Mental Health ProfessionalsAPA Corresponding Committee on Mental Health and Schools; Chair: Marcia J.
CW29. The National Health Information Network and Psychiatry: How Will
Electronic Health Records Impact Our Patients and Our Practice?APA
Corresponding Committee on Electronic Health Records; Chair: Farrell Hobbs
IW28. Psychiatry in the Primary Care Setting: Making It Work for
Patients and DoctorsChair: John C. Urbaitis, M.D.
IW29. The Utility of Computer-Assisted Psychoeducation for Residential
Treatment of Veterans With PTSDChair: Daniella David, M.D.
IW30. How Does Culture Make a Difference in American Mental Health Care?
Culturally Specific Care in Changing ContextsChair: Lawrence T. Park,
IW31. The Provider's Pursuit of Cultural Competence: A Biopsychosocial
QuestChair: Richard K. Harding, M.D.
IW32. 1:1 Observation in a General Hospital Setting: Issues and
RecommendationsChair: Nyapati Rao, M.D.
IW33. Recognition and Management of Neuroleptic Malignant SyndromeChair: Andrew J. Francis, M.D.
IW34. Involuntary Hospitalization of Medical Patients Who Lack
Decisional Capacity: An Unresolved IssueChair: Nancy Byatt,
IW35. How to Involve Your Patients With Bipolar Disorder in Their
Treatment Plan: A Guideline for CliniciansChair: Heinz Grunze,
IW36. Maintenance of Certification for Diplomates of the American Board
of Psychiatry and NeurologyChair: Larry R. Faulkner, M.D.
IW37. How to Launch a Successful Private Practice: Part IChair:
Martin G. Tracy, J.D.
IW38. Interpreting and Disseminating Findings From an Evidence-Based
Drug Review: Antiepileptic Drugs for Mood DisordersChair: John M.
IW39. Planned Care for Depression: A Program for the Management of
Depression in Primary CareChair: Robert C. Joseph, M.D.
L12.A. John Rush, M.D., APA's Award for Research in
L13.John Krystal, M.D., Distinguished Psychiatrist Lecture
L14.Apisamai Sriangson, M.D., International Lecture
Small Interactive Sessions
1. Meet the Author Jon E. Grant, M.D.
2. Meet the Author Eric Hollander, M.D.
MP3. When the Levees Broke: A Requiem in Four Acts By Spike
Lee—The Psychiatric Dimensions of Hurricane KatrinaAPA Council
on Minority Mental Health and Health Disparities; Chair: Francis G. Lu,
MP4. "Thirteen": Parenting and Treating the Addicted
TeenagerAPA Corresponding Committee on Treatment Services for
Patients With Addictive Disorders; Chair: Petros Levounis, M.D.
AM02. Advances in the Cause, Treatment, and Psychology of
HypertensionMichael Ziegler, M.D.
CW30. Passageways: Psychological Routes to Delinquency and Therapeutic
Options Out of the Juvenile Justice SystemAPA Corresponding
Committeeon Juvenile Justice Issues; Chair: Camilla Lyons,
CW31. Dementia in Down Syndrome: Risk Factors, Biomarkers, Diagnosis,
and TreatmentAPA Council on Aging; Chair: John M. De Figueiredo,
CW32. Spiritus Contra Spiritum: The Strange Case of Spirituality and
Addiction: Discussion of the 2007 Oskar Pfister Award LectureAPA
Corresponding Committee on Religion, Spirituality, and Psychiatry; Chair:
George E. Vaillant, M.D.
CW33. Should the Community Replace the Asylum in the 21st Century?APA Lifers; Chair: Sheila Hafter Gray, M.D.
CW34. Novel Careers in Psychiatry: Women Who Have Made Their Own WayAPA Committee on Women; Chair: Melva I. Green, M.D.
CW35. Focusing on Asia: A Review of Disasters, Intervention, and
Prevention ProgramsAPA Council on Global Psychiatry; Chair: Pedro
CW36. HIV and Metabolic SyndromeAPA Committee on AIDS; Chair:
Marshall Forstein, M.D.
IW40. Second Opinion Consultation on Ongoing Psychotherapy
TreatmentsChair: Mardi Horowitz, M.D.
IW41. Privacy and Confidentiality Concerns in Shared Electronic Health
RecordsChair: Benjamin Liptzin, M.D.
IW42. Methamphetamine Abuse and Addiction: Prevalence and TreatmentNational Institute on Drug Abuse; Chair: Ahmed M. Elkashef, M.D.
IW43. How to Launch a Successful Private Practice: Part IIChair: William E. Callahan Jr., M.D.
IW44. Psychiatry in the Americas: Update From the World Psychiatric
AssociationChair: Michelle B. Riba, M.D.
IW45. Assessing Violence Risk Among Persons With Mental IllnessesChair: Paul S. Appelbaum, M.D.
IW46. Psychiatric Expert Testimony: Increased Scrutiny, Increased
LiabilityChair: Philip Merideth, M.D.
IW47. Quality of Life of Patients With Major Depression in a Natural
Clinical SettingChair: Waguih William IsHak, M.D.
IW48. Are Sex Offenders Criminally Responsible?Chair: Renee M.
IW49. Impact of Patient Suicide on Psychiatry Residents: A Workshop
DiscussionChair: Christina Mangurian, M.D.
IW50. Physical Trauma as a Result of War or Natural Disaster:
Psychiatric InterventionsChair: Geoffrey M Gabriel, M.D.
L15. The Future of Psychiatry: International PerspectivesNorman
H. Sartorius, M.D., International Lecture Series
L16. The Neurobiology of Free Will in Addictive DisordersNora
Volkow, M.D., Frontiers of Science Lecture Series
L17. New Neurons in the Adult BrainFred H. Gage, Ph.D.,
Frontiers of Science Lecture Series
Scientific and Clinical Reports Session 10. Medical and Metabolic
Consequences of Psychiatric Treatment
28. Metabolic Abnormalities in Psychiatric Inpatients John W. Goethe,
29. Neuroleptic Malignant Syndrome Induced by Low-Dose Aripiprazole in
First-Episode Psychosis Harun Evcimen, M.D.
30. Metabolic Abnormalities in Patients With Major Depressive Disorders
John W. Goethe, M.D.
Session 11. Access, Availability, and Utilization of Psychiatric
31. Recurrent Psychiatric Hospitalization William H. Sledge,
32. Reducing the Medical and Financial Burden of Depressive Illness: A Plan
for Improving Health Care Services Lawrence W. Adler, M.D.
33. Psychiatric Hospital Bed Numbers and Economic Factors in the XIX and XX
Centuries—New Analyses Alfonso Ceccherini-Nelli, M.D.
Session 12. International Studies in Schizophrenia
34. Brain Morphology in Schizophrenia Within the Northern Finland 1966
Birth Cohort Matti K. Isohanni, M.D.
35. The ADHES Project in Israel: New Insights in Adherence in Schizophrenia
Yoram Barak, M.D.
36. Schizophrenia in the Offspring of Antenatally Depressed Mothers and
Familial Risk—Follow-Up of the Northern Finland 1966 Birth Cohort
Pirjo H. Maki, M.D.
Session 13. Theoretical and Research Approaches in the Study of
37. Beyond the Clash of Civilizations David A. Rothstein, M.D.
38. Phases of Trauma Recovery Herbert L. Campbell, M.D.
39. Predicting Unresolved PTSS in Earthquake Survivors: A Comparison
Between Decision Analysis and Logistics Regression Keng Shin Lin Sr.,
Session 14. Diagnostic Issues
40. Beyond Bipolar I and II: Evidence for the Validity of the"
Softer" Bipolar Spectrum Camilo J. Ruggero, Ph.D.
41. A Proposal for a New Multiaxial Model of Psychiatric Diagnosis: A
Continuum Patient Model Based on Evolutionary Developmental Gene-Environment
Interaction Hoyle Leigh, M.D.
42. Improving the Understanding of Causality in Psychiatric Research
Stephen B. Shanfield, M.D.
43. CyP Genotyping in Patients Treated for Depression Gualberto Ruano,
44. An Association Between the EPAC-1 Gene and Neuroticism and Anxiety
Christel M. Middeldorp, M.D.
45. Circadian System Polymorphisms and Bipolar Disorder Daniel F.
Session 16. Cross-Cultural Psychiatry
46. Similar Depressive Symptom Patterns in a Population-Based Study of
Turkish and Moroccan Immigrants and Native Dutch Agnes Schrier
47. Prevalence and Correlates of Premenstrual Dysphoric Disorder Among Arab
Primary Care Patients in the United Arab Emirates Ossama Tawakol Osman,
48. Effectiveness of Culturally Sensitive Collaborative Treatment for
Treating Depressed Chinese Americans in Primary Care: A Six-Month Follow-Up
Study Albert Yeung, M.D.
Session 17. Treatment of Psychiatric Disorders in Medically Ill
49. Pilot Trial of Modafinil for Treatment of Depression Symptoms and
Fatigue in Adult Brain-Tumor Patients Thomas A. Kaleita, Ph.D.
50. Intraoperative Cerebral Oxygen Desaturation: A Significant Risk Factor
for Postoperative Delirium in Cardiac Surgery Patients Thomas S. Zaubler,
51. Mood and Anxiety Disorders in Cancer Patients: A Case Series
Catherine L. Mancini, M.D.
Session 18. Evidence-Based and Guideline Approaches to Psychiatric
52. Preparing for Evidence-Based Medication-Related Psychiatric Practice:
The Oregon Experience Jennifer P. Wisdom, Ph.D.
53. Improving Adherence to Treatment Guidelines in Hospitalized Patients
With Bipolar Disorder Thomas E. Smith, M.D.
54. Stepped Care for Anxiety-, Depressive-, and Stress-Related Disorders: A
Randomized, Controlled Trial in Primary Care and Mental Health Care
Desiree Oosterbaan, Ph.D.
Small Interactive Sessions
1. Meet the Author Susan McElroy, M.D.
3. Review of Geriatric Psychiatry: Current IssuesChair:
Christopher C Colenda, M.D.
4. Current Research Advances: APA/NIMH/NIDA/NIAAA/NAMI PerspectivesAPA Council on Global Psychiatry; Chair: Pedro Ruiz, M.D.
S27. Bullying in the Workplace: Associated Health Problems
S28. New Perspectives in Psychodynamic Treatments for Borderline
S29. Aggressive Behavioral Disturbances in Geropsychiatric
S30. Formation of Modern Lesbian and Gay Identities: Personal,
Historical, and Mental Health Perspectives
S31. Research Update on Adolescents With Schizophrenia: Implications for
S32. Mirror Neurons, Empathy, Intuition, and Interpretation:
Understanding the Minds of Others
S33. PTSD Borderline Personality Disorder and Motherhood: Early
Relations, Recognition, and Intervention
S34. Uneasy Partners: The Pharmaceutical Industry and the Psychiatric
S35. Stalking Offenders and Victims
S36. Humane Aspects of Private Practice
S37. Eating Disorders Update
S38. Lumping Versus Splitting in Psychiatric Nosology
S39. Choosing the Right Treatment for Substance Abuse
S40. Ethical Issues in Psychiatric Genetics
S41. Women and Psychiatry Around the World: The Importance of Gender and
S42. Psilocybin and Psychiatry: Recent Research
S43. How to Launch a Successful Private Practice: Part 3
S46. Leadership Discourse: Agents of Change in Mental Health
S47. Depression and Anxiety: Continuous or Categorical? A View From
S48. From Clinical Trials to Real-World Outcomes
S49. Inventory of Stigmatizing Experiences
S50. Consumer Provider Training: Incorporating Individuals in Recovery
Into the Behavioral Workforce
S51. When Usual Treatments Fail: Augmentation Strategies for Refractory
IS28. Cigarette Smoking, Smoking Cessation, and Psychiatric IllnessSupported by Pfizer Inc.
IS29. Am I a Psychiatrist.. .or an Endocrinologist? Coping With
Metabolic Disturbances During the Treatment of SchizophreniaSupported
by Pfizer and Solvay-Wyeth
IS30. Depression in the 21st Century: Keeping the Old, Adding the
NewSupported by Bristol-Myers Squibb Co.
IS31. Understanding the Complexity of Bipolar Mixed EpisodesSupported by Eli Lilly and Co.